CIK 0000876343
- Non-accelerated filer
- Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 943127919
- Phone
- +1 510-521-3390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- 5 Insider Annual Insider Trading Report
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 32,050 shares at $3.12 ($99,996)
- 4 Open-market buy Director bought 32,050 shares at $3.12 ($99,996)
- 4 Other acquisition Director acquired 4,040,523 shares (other)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 370,000 shares at $2.65 ($980,500)
- 4 Open-market sale Sr. VP, COO, and CFO sold 100,000 shares at $2.65 ($265,000)
- 4 Open-market sale Chief Executive Officer sold 270,000 shares at $2.65 ($715,500)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 50,000 shares (option exercise)
Page 15 of 37 · 722 filings